Lyell Immunopharma, Inc. (LYEL)
Nasdaq: LYEL · CIK 0001806952 · United States
Every official Lyell Immunopharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open LYEL filings
Lyell Immunopharma, Inc. documents
- Lyell Immunopharma, Inc. 10-K 2026LYEL 10-K 2026: annual report for fiscal 2026
- Lyell Immunopharma, Inc. 10-K 2025LYEL 10-K 2025: annual report for fiscal 2025
- Lyell Immunopharma, Inc. 10-K 2024LYEL 10-K 2024: annual report for fiscal 2024
- Lyell Immunopharma, Inc. 10-K 2023LYEL 10-K 2023: annual report for fiscal 2023
- Lyell Immunopharma, Inc. 10-K 2022LYEL 10-K 2022: annual report for fiscal 2022
- Lyell Immunopharma, Inc. 10-Q 2026LYEL 10-Q 2026: quarterly report for fiscal 2026
- Lyell Immunopharma, Inc. 10-Q 2025LYEL 10-Q 2025: quarterly report for fiscal 2025
- Lyell Immunopharma, Inc. 10-Q 2024LYEL 10-Q 2024: quarterly report for fiscal 2024
- Lyell Immunopharma, Inc. 10-Q 2023LYEL 10-Q 2023: quarterly report for fiscal 2023
- Lyell Immunopharma, Inc. 10-Q 2022LYEL 10-Q 2022: quarterly report for fiscal 2022
- Lyell Immunopharma, Inc. 8-K 2026LYEL 8-K 2026: current report for fiscal 2026
- Lyell Immunopharma, Inc. 8-K 2025LYEL 8-K 2025: current report for fiscal 2025
- Lyell Immunopharma, Inc. 8-K 2024LYEL 8-K 2024: current report for fiscal 2024
- Lyell Immunopharma, Inc. 8-K 2023LYEL 8-K 2023: current report for fiscal 2023
- Lyell Immunopharma, Inc. 8-K 2022LYEL 8-K 2022: current report for fiscal 2022
- Lyell Immunopharma, Inc. DEF 14A 2026LYEL DEF 14A 2026: proxy statement for fiscal 2026
- Lyell Immunopharma, Inc. DEF 14A 2025LYEL DEF 14A 2025: proxy statement for fiscal 2025
- Lyell Immunopharma, Inc. DEF 14A 2024LYEL DEF 14A 2024: proxy statement for fiscal 2024
- Lyell Immunopharma, Inc. DEF 14A 2023LYEL DEF 14A 2023: proxy statement for fiscal 2023
- Lyell Immunopharma, Inc. DEF 14A 2022LYEL DEF 14A 2022: proxy statement for fiscal 2022
- Lyell Immunopharma, Inc. Form 4 2026LYEL Form 4 2026: insider trading filing for fiscal 2026
- Lyell Immunopharma, Inc. Form 4 2025LYEL Form 4 2025: insider trading filing for fiscal 2025
- Lyell Immunopharma, Inc. Form 4 2024LYEL Form 4 2024: insider trading filing for fiscal 2024
- Lyell Immunopharma, Inc. Form 4 2023LYEL Form 4 2023: insider trading filing for fiscal 2023
- Lyell Immunopharma, Inc. Form 4 2022LYEL Form 4 2022: insider trading filing for fiscal 2022
- Lyell Immunopharma, Inc. S-1 2026LYEL S-1 2026: registration statement for fiscal 2026
- Lyell Immunopharma, Inc. S-1 2025LYEL S-1 2025: registration statement for fiscal 2025
- Lyell Immunopharma, Inc. S-1 2024LYEL S-1 2024: registration statement for fiscal 2024
- Lyell Immunopharma, Inc. S-1 2023LYEL S-1 2023: registration statement for fiscal 2023
- Lyell Immunopharma, Inc. S-1 2022LYEL S-1 2022: registration statement for fiscal 2022
- Lyell Immunopharma, Inc. 13F 2026LYEL 13F 2026: institutional holdings for fiscal 2026
- Lyell Immunopharma, Inc. 13F 2025LYEL 13F 2025: institutional holdings for fiscal 2025
- Lyell Immunopharma, Inc. 13F 2024LYEL 13F 2024: institutional holdings for fiscal 2024
- Lyell Immunopharma, Inc. 13F 2023LYEL 13F 2023: institutional holdings for fiscal 2023
- Lyell Immunopharma, Inc. 13F 2022LYEL 13F 2022: institutional holdings for fiscal 2022
More companies